Fig. 7.
Fig. 7. Presence of p210BCR/ABL in normal CD34+ cells delays apoptosis. / p210-eGFP– or eGFP-transduced GFP+ CD34+ cells (104) from 4 cord blood samples were plated in serum-free medium with or without 500 pg/mL rhIL-3 for 2 days. The number of CFCs was determined in fresh and 2-day culture cells by plating 104 cells or their culture progeny in methylcellulose assay. Percentage CFCs that survived the 2-day culture was calculated as (no. CFCs in 2-day progeny/no. CFCs in fresh cells) × 100. Comparison between p210-eGFP– and eGFP-transduced GFP+CD34+ cells (P = .001). ▪, eGFP/no IL-3; ▵, eGFP/+IL-3; ♦, p210-eGFP/no IL-3; ○, p210-eGFP/+IL-3.

Presence of p210BCR/ABL in normal CD34+ cells delays apoptosis.

p210-eGFP– or eGFP-transduced GFP+ CD34+ cells (104) from 4 cord blood samples were plated in serum-free medium with or without 500 pg/mL rhIL-3 for 2 days. The number of CFCs was determined in fresh and 2-day culture cells by plating 104 cells or their culture progeny in methylcellulose assay. Percentage CFCs that survived the 2-day culture was calculated as (no. CFCs in 2-day progeny/no. CFCs in fresh cells) × 100. Comparison between p210-eGFP– and eGFP-transduced GFP+CD34+ cells (P = .001). ▪, eGFP/no IL-3; ▵, eGFP/+IL-3; ♦, p210-eGFP/no IL-3; ○, p210-eGFP/+IL-3.

Close Modal

or Create an Account

Close Modal
Close Modal